Rapid progress towards the development of potent vaccines can only happen through concerted and coordinated efforts in Europe and Worldwide.
Towards a sustainable European vaccine infrastructure
TIMELINE
01 June 2020 to 31 May 2022
FUNDING
1.88 M Euro
TRANSVAC-DS aims to consolidate the conceptual and technical design and ultimate implementation of a European vaccine R&D infrastructure.
TRANSVAC-DS Work package structure and flow:
Work packages
WP
Input
Feasibly
and
option analysis
Gaps & needs analysis and context analysis of research infrastructure landscape
Stakeholder engagement startegy
Socio-economic impact analysis
Ethics
Communication and Dissemination
Recent News:
This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement N° 951668.
This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement N° 951668.
Apply for Vaccine R&D services and Training:
Connect
